CoChat

Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease

Open access
Creese, Byron, Vassos, Evangelos, Bergh, Sverre, Athanasiu, Lavinia, Johar, Iskandar, Rongve, Arvid, Medbøen, Ingrid Tøndel, Vasconcelos Da Silva, Miguel, Aakhus, Eivind, Andersen, Fred, Bettella, Francesco, Braekhus, Anne, Djurovic, Srdjan, Paroni, Giulia, Proitsi, Petroula, Saltvedt, Ingvild, Seripa, Davide, Stordal, Eystein, Fladby, Tormod, Aarsland, Dag, Andreassen, Ole A., Ballard, Clive, Selbaek, Geir, on behalf of the AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative · 2019 · Translational Psychiatry
Cited by 54

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Psychosis (delusions or hallucinations) in Alzheimer’s disease (AD + P) occurs in up to 50% of individuals and is associated with significantly worse clinical outcomes. Atypical antipsychotics, first developed for schizophrenia, are commonly used in AD + P, suggesting shared mechanisms. Despite this implication, little empirical research has been conducted to examine whether there are mechanistic similarities between AD + P and schizophrenia. In this study, we tested whether polygenic risk score (PRS) for schizophrenia was associated with AD + P. Schizophrenia PRS was calculated using Psychiatric Genomics Consortium data at ten GWAS p value thresholds ( P T ) in 3111 AD cases from 11 cohort studies characterized for psychosis using validated, standardized tools. Association between PRS and AD + P status was tested by logistic regression in each cohort individually and the results meta-analyzed. The schizophrenia PRS was associated with AD + P at an optimum P T of 0.01. The strongest association was for delusions where a one standard deviation increase in PRS was associated with a 1.18-fold increased risk (95% CI: 1.06–1.3; p = 0.001). These new findings point towards psychosis in AD—and particularly delusions—sharing some genetic liability with schizophrenia and support a transdiagnostic view of psychotic symptoms across the lifespan.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-019-0592-5

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 54

Metadata

Authors
Creese, B., Vassos, E., Bergh, S., Athanasiu, L., Johar, I., Rongve, A., Medbøen, I. T., Vasconcelos Da Silva, M., Aakhus, E., Andersen, F., Bettella, F., Braekhus, A., Djurovic, S., Paroni, G., Proitsi, P., Saltvedt, I., Seripa, D., Stordal, E., Fladby, T., Aarsland, D., Andreassen, O. A., Ballard, C., Selbaek, G., & on behalf of the AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative
Venue
Translational Psychiatry
Published
2019-10-22
Volume
9
Issue
1
Pages
273-273
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2971428495
Cited by
54
References
7
FWCI
5.80
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease. https://app.cochat.ai/papers/10.1038/s41398-019-0592-5
The paper
Creese, B., Vassos, E., Bergh, S., Athanasiu, L., Johar, I., Rongve, A., Medbøen, I. T., Vasconcelos Da Silva, M., Aakhus, E., Andersen, F., Bettella, F., Braekhus, A., Djurovic, S., Paroni, G., Proitsi, P., Saltvedt, I., Seripa, D., Stordal, E., Fladby, T., . . . on behalf of the AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative. (2019). Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease. Translational Psychiatry. https://doi.org/10.1038/s41398-019-0592-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.